Introduction
Hexarelin and GHRP-2 are among the most potent growth hormone secretagogues (GHS) available for research. Both activate the ghrelin receptor (GHS-R1a) to stimulate pituitary GH release, but they differ in peak potency, desensitization kinetics, cardiac effects, and side effect profiles. Hexarelin is often cited as the single most potent GHS for acute GH release, while GHRP-2 offers the best balance of potency and sustained efficacy.
Mechanism of Action Comparison
Hexarelin is a hexapeptide (His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2) that produces the highest acute GH peak of any synthetic secretagogue. However, it also stimulates cortisol and prolactin more than other GHS and is notably susceptible to receptor desensitization with repeated dosing — GH release diminishes significantly after 4-8 weeks of continuous use. Uniquely, hexarelin also exhibits cardioprotective properties through CD36 scavenger receptor binding, independent of its GH-releasing activity.
GHRP-2 (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2) produces slightly lower peak GH levels than hexarelin but maintains efficacy better over time with less pronounced desensitization. Its cortisol and prolactin elevation is moderate — higher than Ipamorelin but lower than hexarelin or GHRP-6.
Key Differences
| Feature | Hexarelin | GHRP-2 |
|---|---|---|
| Acute GH Potency | Highest of all GHS | Very high (slightly less than hexarelin) |
| Desensitization | Significant (4-8 weeks) | Moderate (better sustained) |
| Cortisol Elevation | Significant | Mild-moderate |
| Prolactin Elevation | Significant | Mild-moderate |
| Cardiac Effects | Cardioprotective (CD36) | Minimal direct cardiac effects |
| Appetite Stimulation | Moderate | Mild |
Research Applications
Hexarelin is particularly valuable in cardiac research due to its unique CD36-mediated cardioprotective effects, which are independent of GH release. It is also used in studies requiring maximum acute GH peak measurement. GHRP-2 is preferred for sustained GH research protocols, body composition studies, and experiments requiring consistent GH stimulation over weeks to months without significant desensitization.
Which to Choose for Your Research?
For acute GH peak studies, cardiac protection research, or short-term protocols where desensitization is not a concern, hexarelin provides the most potent signal. For longer-term GH studies requiring sustained efficacy, GHRP-2 is the better choice due to its resistance to desensitization. For the cleanest GH signal overall, however, ipamorelin remains the gold standard despite lower peak potency.
